Connect your AI

Envoy Medical COCH Price / sales

Price / sales at other companies

Inspire Medical SystemsINSP

1.6×-4.0×

Other financials

Income statement

Revenue$39.0K-15.2%

Gross profit-$274.0K-52.2%

Operating income-$6.0M-16.7%

Net income-$4.4M+12.9%

EPS (diluted)-$0.08+72.4%

Balance sheet

Cash & equivalents$25.3M+376%

Total debt$919.0K-2.8%

Total equity$10.2M+142%

Total assets$29.8M+187%

Cash flow

Operating cash flow-$6.1M-62.7%

CapEx$172.0K—

Free cash flow-$5.9M-28.5%

Valuation

Market cap$61M+83.5%

Profitability

Gross margin-310.7%+31.6pp

Operating margin-9,881.2%+805pp

Net margin-9,875.6%+771pp

FCF margin-7,626.6%-652pp

Returns & leverage

Return on equity328.7%—

Debt / equity0.1×—

Current ratio2.3×+1.2×

Where this comes from

Calculated from Envoy Medical’s reported figures.

market cap/total revenue=218.5×

Based on the most recent quarter.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Envoy Medical's price / sales?: Envoy Medical (COCH) reported price / sales of 218.5× in Q1 2026.
How has Envoy Medical's price / sales changed year-over-year?: Envoy Medical's price / sales increased by 67.4% year-over-year, from 130.6× to 218.5×.
What is the long-term trend for Envoy Medical's price / sales?: Over 2 years (2023 to 2025), Envoy Medical's price / sales has grown at a -15.9% compound annual growth rate (CAGR), from 112.3× to 79.4×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.